Outlook Therapeutics (OTLK) Misses Q3 EPS by 44c
Get Alerts OTLK Hot Sheet
Join SI Premium – FREE
Outlook Therapeutics (NASDAQ: OTLK) reported Q3 EPS of ($0.44). Revenue for the quarter came in at $1.51 million.
For earnings history and earnings-related data on Outlook Therapeutics (OTLK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share